Many LRRK2-related mutations have been reported in PD patients, among which only 6 of these mutations (R1441C/G/H, Y1699C, I2020T and G2019S ) located in the central catalytic ROC-COR-kinase triple domain are clearly pathogenic [66, 67]. This evidence concerns the gene LRRK2 and Parkinson disease.